Roy H Hamilton Selected Research

Aphasia (Dysphasia)

1/2022	Genetic and Neurophysiological Biomarkers of Neuroplasticity Inform Post-Stroke Language Recovery.
1/2022	Through Thick and Thin: Baseline Cortical Volume and Thickness Predict Performance and Response to Transcranial Direct Current Stimulation in Primary Progressive Aphasia.
1/2019	Continuous theta burst stimulation over right pars triangularis facilitates naming abilities in chronic post-stroke aphasia by enhancing phonological access.
12/2017	Functional Reorganization of Right Prefrontal Cortex Underlies Sustained Naming Improvements in Chronic Aphasia via Repetitive Transcranial Magnetic Stimulation.
1/2016	Non-invasive Brain Stimulation in the Treatment of Post-stroke and Neurodegenerative Aphasia: Parallels, Differences, and Lessons Learned.
1/2015	Individualized treatment with transcranial direct current stimulation in patients with chronic non-fluent aphasia due to stroke.
12/2013	Induction of neuroplasticity and recovery in post-stroke aphasia by non-invasive brain stimulation.
7/2011	Mechanisms of aphasia recovery after stroke and the role of noninvasive brain stimulation.
1/2011	Noninvasive brain stimulation in the treatment of aphasia: exploring interhemispheric relationships and their implications for neurorehabilitation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roy H Hamilton Research Topics

Disease

10	Stroke (Strokes) 01/2022 - 04/2010
9	Aphasia (Dysphasia) 01/2022 - 01/2011
4	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 11/2011
4	Primary Progressive Aphasia 01/2022 - 01/2017
4	Wernicke Aphasia (Receptive Aphasia) 01/2015 - 04/2010
2	Epilepsy (Aura) 03/2024 - 09/2023
2	Dementia (Dementias) 01/2019 - 03/2012
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Frontotemporal Dementia (Semantic Dementia) 01/2017
1	Anomia (Dysnomia) 01/2017
1	Brain Injuries (Brain Injury) 09/2016
1	Broca Aphasia (Expressive Aphasia) 10/2012
1	Dyslexia (Alexia) 07/2012
1	Normal Pressure Hydrocephalus 03/2012
1	Amyloid Plaque 11/2011

Drug/Important Bio-Agent (IBA)

2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 01/2022
2	salicylhydroxamic acid (SHAM)IBA 01/2017 - 01/2015
1	lecanemabIBA 11/2023
1	Monoclonal AntibodiesIBA 11/2023
1	Amyloidogenic ProteinsIBA 11/2023
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	SynucleinsIBA 01/2019
1	Amyloid beta-PeptidesIBA 03/2012
1	flutemetamolIBA 11/2011
1	Amyloid (Amyloid Fibrils)IBA 11/2011
1	PlasticsIBA 07/2011

Therapy/Procedure

11	Transcranial Direct Current Stimulation 01/2022 - 01/2011
11	Transcranial Magnetic Stimulation 01/2022 - 04/2010
2	Ambulatory Care (Outpatient Care) 03/2024 - 09/2023
1	Therapeutics 11/2023
1	Off-Label Use 01/2022
1	Language Therapy (Language Training) 08/2020
1	Ventriculoperitoneal Shunt 03/2012
1	Neurological Rehabilitation 01/2011